<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02535780</url>
  </required_header>
  <id_info>
    <org_study_id>13-2716</org_study_id>
    <nct_id>NCT02535780</nct_id>
  </id_info>
  <brief_title>Transcranial Treatments in Eating Disorders</brief_title>
  <official_title>Novel Transcranial Treatments to Modulate Taste Reward and Body Perception Pathways in Eating Disorders</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Colorado, Denver</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Colorado, Denver</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The primary aim of this study is to study how Repetitive Transcranial Magnetic Stimulation&#xD;
      (rTMS) tailored to specific anorexia nervosa (AN) or bulimia nervosa (BN) brain activation&#xD;
      alterations will promote recovery and to study how inhibitory tDCS (Transcranial Direct&#xD;
      Current Stimulation) will reduce symptoms of body image distortion in a second sample of AN&#xD;
      and BN groups.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Study procedures and time not feasible due to patient schedule&#xD;
  </why_stopped>
  <start_date>August 2015</start_date>
  <completion_date type="Actual">June 2016</completion_date>
  <primary_completion_date type="Actual">June 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>taste reward brain function activation confirmed by Functional magnetic resonance imaging (fMRI)</measure>
    <time_frame>3 years</time_frame>
    <description>Change in brain activation to taste reward paradigm</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in self-reported measures related to eating disorder thoughts and behaviors</measure>
    <time_frame>3 years</time_frame>
    <description>Self Assessment</description>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">1</enrollment>
  <condition>Anorexia Nervosa</condition>
  <condition>Bulimia Nervosa</condition>
  <arm_group>
    <arm_group_label>TMS Treatment Group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>15 sessions active Transcranial magnetic stimulation (TMS) treatment</description>
  </arm_group>
  <arm_group>
    <arm_group_label>TMS Sham Group</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>15 sessions sham Transcranial magnetic stimulation (TMS) treatment</description>
  </arm_group>
  <arm_group>
    <arm_group_label>tDCS Treatment Group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>15 sessions active Transcranial direct current stimulation (tDCS) treatment</description>
  </arm_group>
  <arm_group>
    <arm_group_label>tDCS Sham Group</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>15 sessions sham Transcranial direct current stimulation (tDCS) treatment</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Transcranial magnetic stimulation</intervention_name>
    <description>TMS</description>
    <arm_group_label>TMS Sham Group</arm_group_label>
    <arm_group_label>TMS Treatment Group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Transcranial direct current stimulation</intervention_name>
    <description>tDCS</description>
    <arm_group_label>tDCS Sham Group</arm_group_label>
    <arm_group_label>tDCS Treatment Group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Anorexia Nervosa subjects:&#xD;
&#xD;
          -  Meets DSM-5 criteria for anorexia nervosa (AN) either binge-eating/purging type or&#xD;
             restricting-type:&#xD;
&#xD;
          -  Intense fear of gaining weight or becoming fat, even though underweight.&#xD;
&#xD;
          -  The ability to undergo an MRI, fMRI or other similar procedure requiring spending time&#xD;
             in an enclosed space&#xD;
&#xD;
          -  Bulimia Nervosa subjects:&#xD;
&#xD;
          -  Meet DSM-5 criteria for bulimia nervosa (BN):&#xD;
&#xD;
          -  Self-induced vomiting; misuse of laxatives, diuretics, enemas, medication, fasting,&#xD;
             excessive exercise.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Electrolyte, blood count or kidney or liver function abnormalities.&#xD;
&#xD;
          -  No symptoms of alcohol or other substance abuse or dependence in the past 3 months,&#xD;
&#xD;
          -  No previous or current organic brain syndromes, dementia, psychotic disorders,&#xD;
             somatization disorders, or conversion disorder, head trauma, indication of mental&#xD;
             retardation or pervasive developmental disorder.&#xD;
&#xD;
          -  No antipsychotics, tricyclic antidepressants or Wellbutrin or other medication that&#xD;
             may lower the seizure threshold.&#xD;
&#xD;
          -  Claustrophobia.&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Guido K. Frank, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Colorado, Denver</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Colorado Denver and Health Science Center</name>
      <address>
        <city>Aurora</city>
        <state>Colorado</state>
        <zip>80045</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>July 2016</verification_date>
  <study_first_submitted>August 6, 2015</study_first_submitted>
  <study_first_submitted_qc>August 28, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 31, 2015</study_first_posted>
  <last_update_submitted>July 21, 2016</last_update_submitted>
  <last_update_submitted_qc>July 21, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 25, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anorexia</mesh_term>
    <mesh_term>Bulimia</mesh_term>
    <mesh_term>Feeding and Eating Disorders</mesh_term>
    <mesh_term>Anorexia Nervosa</mesh_term>
    <mesh_term>Bulimia Nervosa</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

